BALPHARMA.NSBALPHARMA.NSNSE
Loading
Revenue PerformanceStable
Percentile Rank93
3Y CAGR+0.6%
5Y CAGR+4.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+0.6%/yr
vs +7.8%/yr prior
5Y CAGR
+4.6%/yr
Recent deceleration
Acceleration
-7.3pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$3.09B+2.1%
2025$3.03B-10.7%
2024$3.39B+11.5%
2023$3.04B+8.2%
2022$2.81B+13.9%
2021$2.47B+44.3%
2020$1.71B-24.0%
2019$2.25B+7.5%
2018$2.09B-8.6%
2017$2.29B-